Effects of interferon-α treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C

Immunopharmacology and Immunotoxicology

Volumn 18, Issue 4, 1996, Pages 529-548

  Piazzolla, Giuseppina ^a,c   Giannelli, Gianluigi ^a   Antonelli, Guido ^b   Tortorella, Cosimo ^a   Jirillo, Emilio ^a   Schiraldi, Oronzo ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HLA ANTIGEN CLASS 1; SUPEROXIDE;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; METABOLISM; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

HEPATITIS C VIRUS;

EID: 0029803915     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979609052752     Document Type: Article

References (42)

1. Seeff, L.B., Buskell-Bales, Z., Wright, E.G., Durako, S.J., Alter, H.J., Iber, F.L., Hollinger, F.B., Gitnick, G., Knodell, R.G., Perrillo, R.P., Stevens, C.E., Hollingsworth,C.G., and the National Heart, Lung and Blood Institute Study Group, Long-term mortality after transfusion-associated non-A, non-B hepatitis, N. Engl. J. Med., 327:1906, 1992.
2. Di Bisceglie, A.M., Goodman, Z.D., Ishak, K.G., Hoofnagle, J,H., Melpolder, J.J., Alter, H.J., Long-term clinical and histological follow-up of chronic post-transfusion hepatitis, Hepatology, 14:969, 1991.
3. Koziel, M.J, Dudley, D., Wong, J.T., Dienstag, J., Houghton, M., Ralston, R., Walker, B.D., Intrahepatic cytotqxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis, J. Immunol., 149:3339, 1992.
4. Ballardini, G., Groff, P., Pontisso, P., Giostra, F., Francesconi, R., Lenzi, M., Zauli, D., Alberti, A., Bianchi, F.B., Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules, J.Clin. Invest., 95:2067, 1995.
5. Fiore, G., Jirillo, E., Schiraldi, O., Antonaci, S., Hepatitis C virus infection: biological and immunological features, Rec. Progr. Med., 87:1, 1996.
6. Botarelli, P., Brunetto, M.R., Minutello, M.,A., Calyo, P., Unutmaz, D., Weiner, A.J., Choo, Q.L., Shuster, J.R., Kuo, G., Bonino,F., Houghton, M., Abrignani, S., T-lymphocyte response to hepatitis C virus in different clinical courses of infection, Gastroenterology, 104:580, 1993.
7. Cerny, A., Chisari, F.V., Immunological aspects of HCV infection, Intervirology, 37:119-125, 1994.
8. Karino, Y., Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis, Hokkaido-Igaku-Zasshi, 68:297, 1993.
9. Quiroga, J.A., Martin, J., Pardo, M., Carreno, V., Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α, Dig. Dis. Sci., 39:2485, 1994.
10. Puppo, F., Picciotto, A., Brenci, F., Varagona, G., Scudoletti, M., Ghio, M., Balestra, V., Celle, G., Indiveri, F., Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor of response?, J. Clin. Immunol., 15:179, 1995.
11. Jirillo, E., Greco, B., Caradonna, L, Satalino, L., Pugliese, V., Cozzolongo, R., Cuppone, R., Manghisi, O.G., Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus (cHCV) infection, Immunopharmacol. Immunotoxicol., 17:347, 1995.
12. Giannelli, G., Piazzolla, G., Tortorella, C., Jirillo, E., Schiraldi, O., Antonaci, S., Neutrophil oxidative responsiveness in chronic hepatitis C, Med. Sci. Res. 24:99, 1996.
13. Davis, G.L., Balart, L.A., Schiff, E.R., Lindsay, K., Bodenheimer, H.C. Jr, Perrillo, R.P., Carey, W., Jacobson, L.M., Payne, J., Dienstag, J.L., Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial, N. Engl. J. Med., 321:1501, 1989.
14. Di Bisceglie, A.M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S.M., Hoffnagle, J.H., Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial, N. Engl. J. Med., 321:1506, 1989.
15. Krim, M., Towards tumor therapy with interferons, part. I. Interferons: production and properties, Blood, 55:711, 1980.
16. Harfast, B., Huddlestone, J.R., Casali, P., Merigan, T.C., Oldstone, M.B.A., Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis, J. Immunol., 127:2146, 1981.
17. Shalaby, M.R., Aggarwal, B.B., Rinderknecht, E., Svedersky, L.P., Finkle, B.S., Palladino, M.A. Jr., Activation of human polymorphonuclear neutrophil functions by interferon-τ and tumor necrosis factors, J. Immunol., 135:2069, 1985.
18. Jirillo, E., Greco, B., Satalino, R., Amati, L, Cozzolongo, R., Cuppone, R., Manghisi, O.G., Immunological effects following administration of interferon-α in patients with chronic hepatitis C virus (cHCV) infection, Immunopharmacol. Immunotoxicol., 18:000, 1996.
19. Garson, J.A., Tedder, R.S., Briggs, M., Tuke, P., Glazebrook, J.A., Trute, A., Parker, D., Barbara, J.A.J., Contreras, M., Aloysius, S., Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity, Lancet, 335:1419, 1990.
20. Böyum, A., Isolation of mononuclear cells and granulocytes from human blood, Scand. J. Clin. Lab. Invest., 21 (suppl. 97):77, 1968.
21. Gerlier, D, Thomasset, N., Use of MTT colorimetric assay to measure cell activation, J. Immunol. Methods, 94:57, 1986.
22. Yakuwa, N., Inoue, T., Watanabe, T., Takahashi, K., Sendo, F., A novel neutrophil adherence test effectively reflects the activated state of neutrophils, Microbiol. Immunol., 33:843, 1989.
23. Babior, B.M., Kipnes, R.S., Curnutte, J.T., Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent, J. Clin. Invest., 52:741, 1973.
24. Uehara, M., Sato, N., Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma, Hepatology, 13:267, 1991.
25. Tortorella, C., Ottolenghi, A., Pugliese, P., Jirillo, E., Antonaci, S., Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells, Mech. Age. Dev., 69:53, 1993.
26. Hoofnagle, J.H., Mullen, K.D., Jones, D.B., Rustgi, V., Di Bisceglie, A., Peters, M., Waggoner, J.G., Park, Y., Jones, E.A., Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report, N. Engl. J. Med., 315:1575, 1986.
27. Tiné, F., Magrin, S., Craxi, A., Pagliaro, L, Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomized clinical trials, J. Hepatol. 13:192, 1991.
28. Missale, G., Rochford, R., Hobbs, M., Ferrari, C., Fiaccadori, F., Chisari, F.V., Intrahepatic cytokine messenger RNA expression in chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, Ital. J. Gastroenterol., 26:209, 1994.
29. Humbert, J.R., Winsor, E.L., Tumor Necrosis Factor primes neutrophils by shortening the lag period of the respiratory burst, Am. J. Med. Sci., 300:209, 1990.
30. Kishihara, Y., Hayashi, J., Yoshimura, E., Yamaji, K., Nakashima, K., Kashiwagi, S., IL-1ß and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C, Dig. Dis. Sci., 41:315, 1996.
31. Rosser, B.G., Gores, G.J., Liver cell necrosis: cellular mechanisms and clinical implications, Gastroenterology, 108:252, 1995.
32. Tsukamoto, H., Kim, C.W., Luo, Z.Z., Horne, W., Su, L-E., Brittenham, G., Role of lipid peroxidation in in vivo and in vitro models of liver fibrogenesis, Gastroenterology, 104:A1012, 1993.
33. Tsukamoto, H., Rippe, R., Niemela, O., Lin, M., Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis, J. Gastroenterol. Hepatol., 10:S50, 1995.
34. Jiménez, S.A., Freundlich, B., Rosenbloom, T., Selective inhibition of human diploid fibroblast collagen synthesis by interferons, J. Clin. Invest., 74:1112, 1984.
35. Castilla, A., Prieto, J., Fausto, N., Transforming growth factors ß1 and α in chronic liver disease. Effects of interferon alfa therapy, N. Engl. J. Med., 324:933, 1991.
36. Higueras, V., Raya, A., Rodrigo, J.M., Serra, M.A., Roma, J., Romero, F.J., Interferon decreases serum lipid peroxidation products of hepatitis C patients, Free Radic. Biol. Med., 16:131, 1994.
37. 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation, Hepatology, 18:1344, 1993.
38. Raptopoulou-Gigi, M., Orphanou-Koumerkeridou, H., The effect of interferon on activated peripheral blood T lymphocytes in patients with chronic active hepatitis B, Immunopharmacol. Immunotoxicol., 16:577, 1994.
39. Hayashi, J., Kishihara, Y., Yamaji, K., Yoshimura, E., Ohmiya, M., Tani, Y., Ikematsu, H., Kashiwagi, S., Serum levels of soluble Interleukin-2 receptors and effects of interferon-α for patients with chronic hepatitis C virus, Dig. Dis. Sci., 40:1837, 1995.
40. Unutmaz, D., Pileri, P., Abrignani, S., Antigen-independent activation of naive and memory resting T cells by a cytokine combination, J. Exp. Med., 180:1159, 1994.
41. 2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?, J. Hepatol., 19:228, 1993.
42. Brieva, J.A., Villar, L.M., Leoro, G., Alvarez-Cermeño, J.C., Roldan, E., Gonzalez-Porqué, P., Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma, Clin. Exp. Immunol., 82:390, 1990.